As of 2026-02-15, the Intrinsic Value of Revolution Medicines Inc (RVMD) is -12.93 USD. This RVMD valuation is based on the model Peter Lynch Fair Value. With the current market price of 97.99 USD, the upside of Revolution Medicines Inc is -113.19%.
Based on its market price of 97.99 USD and our intrinsic valuation, Revolution Medicines Inc (RVMD) is overvalued by 113.19%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.93 - -12.93 | -12.93 | -113.19% |
| P/E | (50.88) - (56.05) | (53.77) | -154.9% |
| DDM - Stable | (16.71) - (69.13) | (42.92) | -143.8% |
| DDM - Multi | (3.30) - (10.95) | (5.11) | -105.2% |
| Market Cap (mil) | 18,943.43 |
| Beta | 1.28 |
| Outstanding shares (mil) | 193.32 |
| Enterprise Value (mil) | 18,982.49 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.10% |
| Cost of Debt | 5.00% |
| WACC | 8.04% |